Kirkland, Goodwin Guide Lilly's Potential $7B Kelonia Buy

By Jade Martinez-Pogue · April 20, 2026, 1:55 PM EDT

Kirkland & Ellis LLP-advised pharmaceutical giant Eli Lilly & Co. on Monday announced plans to acquire clinical-stage biotechnology company Kelonia Therapeutics, led by Goodwin Procter LLP, in a deal worth up...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login